AI-generated analysis. Always verify with the original filing.
Cocrystal Pharma, Inc. filed an 8-K on March 13, 2026, with Items listed as N/A. The external hint indicates potential disclosure under Item 5.02 regarding departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements, but no specific details are provided in the document content.